RxDoctor Payments Data

Andrew Lerner, MD

Pulmonary Disease · Washington, DCNPI 1962636514

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.7%), education and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Intuitive Surgical at 54.6% of the total. Reporting peaked in 2024 at $8,446 and has fallen 83.2% since, to $1,417 in 2025. Among pulmonary disease clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,277in general payments, 2019–2025

Across 66 payments — averaging $292.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$11K
  • Noah Medical Corporation$6K
  • Johnson & Johnson$2K
  • AstraZeneca$620
  • ERBE USA Inc$160
  • United Therapeutics Corporation$110
  • plus $205 from 5 others

What the payments were for

  • Consulting fees$3,20017%
  • Travel & lodging$8,43144%
  • Food & beverage$2,14711%
  • Education$5,50029%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,277 in reported general payments places this provider in the 90th percentile of 56 pulmonary disease providers in District of Columbia.

See all pulmonary disease providers in District of Columbia

Medicare billing

Part B allowed, 2024
$117,568
Medicare patients
459
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →